Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1169 entries
Sorted by: Best Match Show Resources per page
Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario.

Hepatobiliary surgery and nutrition

Ierardi E, Sorrentino C, Principi M, Giorgio F, Losurdo G, Di Leo A.
PMID: 26312245
Hepatobiliary Surg Nutr. 2015 Aug;4(4):289-92. doi: 10.3978/j.issn.2304-3881.2015.02.01.

Intestinal microbiota is a "dynamic organ" influencing host metabolism, nutrition, physiology and immune system. Among its several interactions, the role of a phosphatidylcholine metabolite derived by gut flora activity, i.e., trimethylamine-N-oxide (TMAO), allows perceiving a novel insight in the...

Cite
Ierardi E, Sorrentino C, Principi M, et al. Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario. Hepatobiliary Surg Nutr. 2015;4(4):289-92doi: 10.3978/j.issn.2304-3881.2015.02.01.
Ierardi, E., Sorrentino, C., Principi, M., Giorgio, F., Losurdo, G., & Di Leo, A. (2015). Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario. Hepatobiliary surgery and nutrition, 4(4), 289-92. https://doi.org/10.3978/j.issn.2304-3881.2015.02.01
Ierardi, Enzo, et al. "Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario." Hepatobiliary surgery and nutrition vol. 4,4 (2015): 289-92. doi: https://doi.org/10.3978/j.issn.2304-3881.2015.02.01
Ierardi E, Sorrentino C, Principi M, Giorgio F, Losurdo G, Di Leo A. Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario. Hepatobiliary Surg Nutr. 2015 Aug;4(4):289-92. doi: 10.3978/j.issn.2304-3881.2015.02.01. PMID: 26312245; PMCID: PMC4526767.
Copy Download .nbib Format: NLM
Smoking prevalence and associated risk factors among healthcare professionals in Nicosia general hospital, Cyprus: a cross-sectional study.

Tobacco induced diseases

Zinonos S, Zachariadou T, Zannetos S, Panayiotou AG, Georgiou A.
PMID: 27057153
Tob Induc Dis. 2016 Apr 07;14:14. doi: 10.1186/s12971-016-0079-6. eCollection 2016.

BACKGROUND: In recent years, a significant progress has been achieved globally in reduction of smoking among physicians and nurses, however, in some countries the smoking prevalence of health professionals is maintained at very high levels, without significant difference from...

Cite
Zinonos S, Zachariadou T, Zannetos S, et al. Smoking prevalence and associated risk factors among healthcare professionals in Nicosia general hospital, Cyprus: a cross-sectional study. Tob Induc Dis. 2016;14:14doi: 10.1186/s12971-016-0079-6.
Zinonos, S., Zachariadou, T., Zannetos, S., Panayiotou, A. G., & Georgiou, A. (2016). Smoking prevalence and associated risk factors among healthcare professionals in Nicosia general hospital, Cyprus: a cross-sectional study. Tobacco induced diseases, 1414. https://doi.org/10.1186/s12971-016-0079-6
Zinonos, Stavri, et al. "Smoking prevalence and associated risk factors among healthcare professionals in Nicosia general hospital, Cyprus: a cross-sectional study." Tobacco induced diseases vol. 14 (2016): 14. doi: https://doi.org/10.1186/s12971-016-0079-6
Zinonos S, Zachariadou T, Zannetos S, Panayiotou AG, Georgiou A. Smoking prevalence and associated risk factors among healthcare professionals in Nicosia general hospital, Cyprus: a cross-sectional study. Tob Induc Dis. 2016 Apr 07;14:14. doi: 10.1186/s12971-016-0079-6. eCollection 2016. PMID: 27057153; PMCID: PMC4823851.
Copy Download .nbib Format: NLM
The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.

The Journal of biological chemistry

Shin J, Carr A, Corner GA, Tögel L, Dávalos-Salas M, Tran H, Chueh AC, Al-Obaidi S, Chionh F, Ahmed N, Buchanan DD, Young JP, Malo MS, Hodin RA, Arango D, Sieber OM, Augenlicht LH, Dhillon AS, Weber TK, Mariadason JM.
PMID: 26092983
J Biol Chem. 2015 Jun 19;290(25):15392. doi: 10.1074/jbc.A114.557546.

No abstract available.

Cite
Shin J, Carr A, Corner GA, et al. The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner. J Biol Chem. 2015;290(25):15392doi: 10.1074/jbc.A114.557546.
Shin, J., Carr, A., Corner, G. A., Tögel, L., Dávalos-Salas, M., Tran, H., Chueh, A. C., Al-Obaidi, S., Chionh, F., Ahmed, N., Buchanan, D. D., Young, J. P., Malo, M. S., Hodin, R. A., Arango, D., Sieber, O. M., Augenlicht, L. H., Dhillon, A. S., Weber, T. K., & Mariadason, J. M. (2015). The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner. The Journal of biological chemistry, 290(25), 15392. https://doi.org/10.1074/jbc.A114.557546
Shin, Joongho, et al. "The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner." The Journal of biological chemistry vol. 290,25 (2015): 15392. doi: https://doi.org/10.1074/jbc.A114.557546
Shin J, Carr A, Corner GA, Tögel L, Dávalos-Salas M, Tran H, Chueh AC, Al-Obaidi S, Chionh F, Ahmed N, Buchanan DD, Young JP, Malo MS, Hodin RA, Arango D, Sieber OM, Augenlicht LH, Dhillon AS, Weber TK, Mariadason JM. The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner. J Biol Chem. 2015 Jun 19;290(25):15392. doi: 10.1074/jbc.A114.557546. PMID: 26092983; PMCID: PMC4505454.
Copy Download .nbib Format: NLM
Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation.

Patient related outcome measures

Maggiolo F, Colombo GL, Di Matteo S, Bruno GM, Astuti N, Di Filippo E, Masini G, Bernardini C.
PMID: 25733942
Patient Relat Outcome Meas. 2015 Feb 17;6:53-60. doi: 10.2147/PROM.S63586. eCollection 2015.

OBJECTIVES: Costs may play a role in deciding how and when to start highly active antiretroviral therapy (HAART) in a naïve patient. The aim of the present study was to assess the cost- effectiveness of treatment with HAART in...

Cite
Maggiolo F, Colombo GL, Di Matteo S, et al. Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation. Patient Relat Outcome Meas. 2015;6:53-60doi: 10.2147/PROM.S63586.
Maggiolo, F., Colombo, G. L., Di Matteo, S., Bruno, G. M., Astuti, N., Di Filippo, E., Masini, G., & Bernardini, C. (2015). Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation. Patient related outcome measures, 653-60. https://doi.org/10.2147/PROM.S63586
Maggiolo, Franco, et al. "Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation." Patient related outcome measures vol. 6 (2015): 53-60. doi: https://doi.org/10.2147/PROM.S63586
Maggiolo F, Colombo GL, Di Matteo S, Bruno GM, Astuti N, Di Filippo E, Masini G, Bernardini C. Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation. Patient Relat Outcome Meas. 2015 Feb 17;6:53-60. doi: 10.2147/PROM.S63586. eCollection 2015. PMID: 25733942; PMCID: PMC4337626.
Copy Download .nbib Format: NLM
Enhancing Root Eminence and Papilla Contour Using Single, Contoured, Subepithelial Connective Tissue Autografts for Recession Coverage.

The International journal of periodontics & restorative dentistry

Lareau DE, Hinrichs JE, Kotsakis GA.
PMID: 28355311
Int J Periodontics Restorative Dent. 2017 September/October;37(5):751–757. doi: 10.11607/prd.2793. Epub 2017 Mar 29.

Current techniques using autogenous soft tissue in periodontal plastic surgery have limitations in the number of teeth that can be treated and may result in suboptimal esthetic results. The innovative use of single, contoured grafts reported in this article...

Cite
Lareau DE, Hinrichs JE, Kotsakis GA. Enhancing Root Eminence and Papilla Contour Using Single, Contoured, Subepithelial Connective Tissue Autografts for Recession Coverage. Int J Periodontics Restorative Dent. 2017;37(5):751–757doi: 10.11607/prd.2793.
Lareau, D. E., Hinrichs, J. E., & Kotsakis, G. A. (2017). Enhancing Root Eminence and Papilla Contour Using Single, Contoured, Subepithelial Connective Tissue Autografts for Recession Coverage. The International journal of periodontics & restorative dentistry, 37(5), 751–757. https://doi.org/10.11607/prd.2793
Lareau, Donald E, et al. "Enhancing Root Eminence and Papilla Contour Using Single, Contoured, Subepithelial Connective Tissue Autografts for Recession Coverage." The International journal of periodontics & restorative dentistry vol. 37,5 (2017): 751–757. doi: https://doi.org/10.11607/prd.2793
Lareau DE, Hinrichs JE, Kotsakis GA. Enhancing Root Eminence and Papilla Contour Using Single, Contoured, Subepithelial Connective Tissue Autografts for Recession Coverage. Int J Periodontics Restorative Dent. 2017 September/October;37(5):751–757. doi: 10.11607/prd.2793. Epub 2017 Mar 29. PMID: 28355311.
Copy Download .nbib Format: NLM
Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii.

Frontiers in microbiology

Lo Cantore P, Giorgio A, Iacobellis NS.
PMID: 26500627
Front Microbiol. 2015 Oct 06;6:1082. doi: 10.3389/fmicb.2015.01082. eCollection 2015.

Pseudomonas tolaasii is the main bacterial pathogen of several mushroom species. In this paper we report that strains of P. tolaasii produce volatile substances inducing in vitro mycelia growth inhibition of Pleurotus ostreatus and P. eryngii, and Agaricus bisporus...

Cite
Lo Cantore P, Giorgio A, Iacobellis NS. Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii. Front Microbiol. 2015;6:1082doi: 10.3389/fmicb.2015.01082.
Lo Cantore, P., Giorgio, A., & Iacobellis, N. S. (2015). Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii. Frontiers in microbiology, 61082. https://doi.org/10.3389/fmicb.2015.01082
Lo Cantore, Pietro, et al. "Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii." Frontiers in microbiology vol. 6 (2015): 1082. doi: https://doi.org/10.3389/fmicb.2015.01082
Lo Cantore P, Giorgio A, Iacobellis NS. Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii. Front Microbiol. 2015 Oct 06;6:1082. doi: 10.3389/fmicb.2015.01082. eCollection 2015. PMID: 26500627; PMCID: PMC4594034.
Copy Download .nbib Format: NLM
Stress effects on the initial lithiation of crystalline silicon nanowires: reactive molecular dynamics simulations using ReaxFF.

Physical chemistry chemical physics : PCCP

Ostadhossein A, Cubuk ED, Tritsaris GA, Kaxiras E, Zhang S, van Duin AC.
PMID: 25559797
Phys Chem Chem Phys. 2015 Feb 07;17(5):3832-40. doi: 10.1039/c4cp05198j. Epub 2015 Jan 05.

Silicon (Si) has been recognized as a promising anode material for the next-generation high-capacity lithium (Li)-ion batteries because of its high theoretical energy density. Recent in situ transmission electron microscopy (TEM) revealed that the electrochemical lithiation of crystalline Si...

Cite
Ostadhossein A, Cubuk ED, Tritsaris GA, et al. Stress effects on the initial lithiation of crystalline silicon nanowires: reactive molecular dynamics simulations using ReaxFF. Phys Chem Chem Phys. 2015;17(5):3832-40doi: 10.1039/c4cp05198j.
Ostadhossein, A., Cubuk, E. D., Tritsaris, G. A., Kaxiras, E., Zhang, S., & van Duin, A. C. (2015). Stress effects on the initial lithiation of crystalline silicon nanowires: reactive molecular dynamics simulations using ReaxFF. Physical chemistry chemical physics : PCCP, 17(5), 3832-40. https://doi.org/10.1039/c4cp05198j
Ostadhossein, Alireza, et al. "Stress effects on the initial lithiation of crystalline silicon nanowires: reactive molecular dynamics simulations using ReaxFF." Physical chemistry chemical physics : PCCP vol. 17,5 (2015): 3832-40. doi: https://doi.org/10.1039/c4cp05198j
Ostadhossein A, Cubuk ED, Tritsaris GA, Kaxiras E, Zhang S, van Duin AC. Stress effects on the initial lithiation of crystalline silicon nanowires: reactive molecular dynamics simulations using ReaxFF. Phys Chem Chem Phys. 2015 Feb 07;17(5):3832-40. doi: 10.1039/c4cp05198j. Epub 2015 Jan 05. PMID: 25559797.
Copy Download .nbib Format: NLM
Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study.

The Journal of international medical research

Potenza C, Raimondi G, Pampena R, Proietti I, Viola G, Bernardini N, Tolino E, Zuber S, Balduzzi V, Scordamaglia B, Skroza N.
PMID: 27683138
J Int Med Res. 2016 Sep;44(1):43-47. doi: 10.1177/0300060515593242.

OBJECTIVE: To assess the influence of etanercept, an anti-tumour necrosis factor (TNF)-α agent, on autonomic cardiovascular regulation in young patients with moderate-to-severe psoriasis without cardiovascular risk factors.METHODS: Patients with psoriasis underwent 5-min electrocardiogram (ECG) recordings before and after 24...

Cite
Potenza C, Raimondi G, Pampena R, et al. Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study. J Int Med Res. 2016;44(1):43-47doi: 10.1177/0300060515593242.
Potenza, C., Raimondi, G., Pampena, R., Proietti, I., Viola, G., Bernardini, N., Tolino, E., Zuber, S., Balduzzi, V., Scordamaglia, B., & Skroza, N. (2016). Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study. The Journal of international medical research, 44(1), 43-47. https://doi.org/10.1177/0300060515593242
Potenza, Concetta, et al. "Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study." The Journal of international medical research vol. 44,1 (2016): 43-47. doi: https://doi.org/10.1177/0300060515593242
Potenza C, Raimondi G, Pampena R, Proietti I, Viola G, Bernardini N, Tolino E, Zuber S, Balduzzi V, Scordamaglia B, Skroza N. Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study. J Int Med Res. 2016 Sep;44(1):43-47. doi: 10.1177/0300060515593242. PMID: 27683138; PMCID: PMC5536535.
Copy Download .nbib Format: NLM
The Impact for Patient Outcomes of Failure to Follow Up on Test Results. How Can We Do Better?.

EJIFCC

Callen J, Georgiou A, Li J, Westbrook JI.
PMID: 27683480
EJIFCC. 2015 Jan 27;26(1):38-46. eCollection 2015 Jan.

BACKGROUND: The World Health Organization-World Alliance for Patient Safety has identified test result management as a priority area. Poor test result follow-up can have major consequences for the quality of care, including missed diagnoses and suboptimal patient outcomes. Over...

Cite
Callen J, Georgiou A, Li J, et al. The Impact for Patient Outcomes of Failure to Follow Up on Test Results. How Can We Do Better?. EJIFCC. 2015;26(1):38-46
Callen, J., Georgiou, A., Li, J., & Westbrook, J. I. (2015). The Impact for Patient Outcomes of Failure to Follow Up on Test Results. How Can We Do Better?. EJIFCC, 26(1), 38-46.
Callen, Joanne, et al. "The Impact for Patient Outcomes of Failure to Follow Up on Test Results. How Can We Do Better?." EJIFCC vol. 26,1 (2015): 38-46.
Callen J, Georgiou A, Li J, Westbrook JI. The Impact for Patient Outcomes of Failure to Follow Up on Test Results. How Can We Do Better?. EJIFCC. 2015 Jan 27;26(1):38-46. eCollection 2015 Jan. PMID: 27683480; PMCID: PMC4975222.
Copy Download .nbib Format: NLM
Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury.

Frontiers in neurology

Lazarus RC, Buonora JE, Flora MN, Freedy JG, Holstein GR, Martinelli GP, Jacobowitz DM, Mueller GP.
PMID: 26441823
Front Neurol. 2015 Sep 22;6:204. doi: 10.3389/fneur.2015.00204. eCollection 2015.

Protein citrullination is a calcium-driven post-translational modification proposed to play a causative role in the neurodegenerative disorders of Alzheimer's disease, multiple sclerosis (MS), and prion disease. Citrullination can result in the formation of antigenic epitopes that underlie pathogenic autoimmune...

Cite
Lazarus RC, Buonora JE, Flora MN, et al. Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury. Front Neurol. 2015;6:204doi: 10.3389/fneur.2015.00204.
Lazarus, R. C., Buonora, J. E., Flora, M. N., Freedy, J. G., Holstein, G. R., Martinelli, G. P., Jacobowitz, D. M., & Mueller, G. P. (2015). Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury. Frontiers in neurology, 6204. https://doi.org/10.3389/fneur.2015.00204
Lazarus, Rachel C, et al. "Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury." Frontiers in neurology vol. 6 (2015): 204. doi: https://doi.org/10.3389/fneur.2015.00204
Lazarus RC, Buonora JE, Flora MN, Freedy JG, Holstein GR, Martinelli GP, Jacobowitz DM, Mueller GP. Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury. Front Neurol. 2015 Sep 22;6:204. doi: 10.3389/fneur.2015.00204. eCollection 2015. PMID: 26441823; PMCID: PMC4585288.
Copy Download .nbib Format: NLM
Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease.

Annals of gastroenterology

Papageorgiou MV, Hadziyannis E, Tiniakos D, Georgiou A, Margariti A, Kostas A, Papatheodoridis GV.
PMID: 28243042
Ann Gastroenterol. 2017;30(2):209-216. doi: 10.20524/aog.2016.0107. Epub 2016 Dec 01.

BACKGROUND: This study aimed to assess the significance of serum levels of vascular endothelial growth factor (VEGF) in non-alcoholic fatty liver disease (NAFLD).METHODS: Sixty-seven consecutive NAFLD patients and 47 healthy controls who visited our liver clinics between May 2008...

Cite
Papageorgiou MV, Hadziyannis E, Tiniakos D, et al. Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease. Ann Gastroenterol. 2016;30(2):209-216doi: 10.20524/aog.2016.0107.
Papageorgiou, M. V., Hadziyannis, E., Tiniakos, D., Georgiou, A., Margariti, A., Kostas, A., & Papatheodoridis, G. V. (2017). Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease. Annals of gastroenterology, 30(2), 209-216. https://doi.org/10.20524/aog.2016.0107
Papageorgiou, Maria-Vasiliki, et al. "Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease." Annals of gastroenterology vol. 30,2 (2017): 209-216. doi: https://doi.org/10.20524/aog.2016.0107
Papageorgiou MV, Hadziyannis E, Tiniakos D, Georgiou A, Margariti A, Kostas A, Papatheodoridis GV. Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease. Ann Gastroenterol. 2017;30(2):209-216. doi: 10.20524/aog.2016.0107. Epub 2016 Dec 01. PMID: 28243042; PMCID: PMC5320034.
Copy Download .nbib Format: NLM
Messenger RNA processing is altered in autosomal dominant leukodystrophy.

Human molecular genetics

Bartoletti-Stella A, Gasparini L, Giacomini C, Corrado P, Terlizzi R, Giorgio E, Magini P, Seri M, Baruzzi A, Parchi P, Brusco A, Cortelli P, Capellari S.
PMID: 28934398
Hum Mol Genet. 2017 Oct 01;26(19):3868. doi: 10.1093/hmg/ddx225.

No abstract available.

Cite
Bartoletti-Stella A, Gasparini L, Giacomini C, et al. Messenger RNA processing is altered in autosomal dominant leukodystrophy. Hum Mol Genet. 2017;26(19):3868doi: 10.1093/hmg/ddx225.
Bartoletti-Stella, A., Gasparini, L., Giacomini, C., Corrado, P., Terlizzi, R., Giorgio, E., Magini, P., Seri, M., Baruzzi, A., Parchi, P., Brusco, A., Cortelli, P., & Capellari, S. (2017). Messenger RNA processing is altered in autosomal dominant leukodystrophy. Human molecular genetics, 26(19), 3868. https://doi.org/10.1093/hmg/ddx225
Bartoletti-Stella, Anna, et al. "Messenger RNA processing is altered in autosomal dominant leukodystrophy." Human molecular genetics vol. 26,19 (2017): 3868. doi: https://doi.org/10.1093/hmg/ddx225
Bartoletti-Stella A, Gasparini L, Giacomini C, Corrado P, Terlizzi R, Giorgio E, Magini P, Seri M, Baruzzi A, Parchi P, Brusco A, Cortelli P, Capellari S. Messenger RNA processing is altered in autosomal dominant leukodystrophy. Hum Mol Genet. 2017 Oct 01;26(19):3868. doi: 10.1093/hmg/ddx225. PMID: 28934398; PMCID: PMC5886215.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1169 entries